Filing Details

Accession Number:
0001140361-17-023684
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-02 20:26:49
Reporting Period:
2017-06-01
Filing Date:
2017-06-02
Accepted Time:
2017-06-02 20:26:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Therapeutics Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1691262 Iii A. Curt Herberts 501 Canal Blvd
Point Richmond Tech Cntr.
Richmond CA 94804
Senior Vp & Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-01 2,000 $6.80 35,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
  2. Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms.